Regulated vs Less-Regulated Markets: How much do prices of Active Pharmaceutical Ingredients (APIs) vary based on destination?

 

After our pricing evaluation of Paracetamol last week, we evaluated the price trends of three commonly used pharmaceutical ingredients to determine whether or not the pharmaceutical world is divided into regulated and less-regulated markets?

View our recent compilation and form your own assessment. 

 
 

 

Pseudoephedrine HCl  

 

Pseudoephedrine Hcl - Price Trend Data Based On Indian Trade Statistics For Q4 2015
  Quantity (kg) Value CIF ($) Average Price ($)
Total exports out of India 35,699 1,864,559 $52.23
Total exports to Regulated Markets 20,252 1,088,668 $53.76
Total exports to Less Regulated Markets 15,447 775,891 $50.23

 

View the Pseudoephedrine Indian trade statistics used to create this compilation

 

Famotidine

 

Famotidine - Price Trend Data Based On Indian Trade Statistics For Q4 2015
  Quantity (kg) Value CIF ($) Average Price ($)
Total exports out of India 13,163 943,679 $71.69
Total exports to Regulated Markets 5,241 560,070 $106.86
Total exports to Less Regulated Markets 7,922 383,609 $48.43

 

View the Famotidine Indian trade statistics used to create this compilation

 

Dextromethorphan Hydrobromide

 

Dextromethorphan Hydrobromide - Price Trend Data Based On Indian Trade Statistics For Q4 2015
  Quantity (kg) Value CIF ($) Average Price ($)
Total exports out of India 26,325 3,235,644 $122.91
Total exports to Regulated Markets 13,990 2,117,323 $151.35
Total exports to Less Regulated Markets 12,335 1,118,321 $90.66

 

View the Dextromethorpan Indian trade statistics used to create this compilation

 

The PharmaCompass Newsletter – Sign Up, Stay Ahead

Feedback, help us to improve. Click here

Image Credit : photoshop contest by Tracy is licensed under CC BY 2.0

“ The article is based on the information available in public and which the author believes to be true. The author is not disseminating any information, which the author believes or knows, is confidential or in conflict with the privacy of any person. The views expressed or information supplied through this article is mere opinion and observation of the author. The author does not intend to defame, insult or, cause loss or damage to anyone, in any manner, through this article.”

Read More